Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2022

Feb 12, 2022

29745_dirs_2022-02-11_f872aca5-a2ee-425a-aaac-b2d98cc80e08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-02-09

Reporting Person: Ricks David A (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-09 Common Stock A 68004 $243.27 Acquired 467783 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-09 Restricted Stock Unit $ A 47786 Acquired 2023-02-01 Common Stock (47786.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 63500 Indirect
Common Stock 7090 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.